Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples
Testing for mutations in the KRAS oncogene for patients with metastatic colorectal cancer (mCRC) is generally performed using DNA from formalin-fixed paraffin-embedded tumor tissue; however, access to specimens can be limited and analysis challenging. This study assessed the identification of KRAS m...
Saved in:
Main Authors: | Shethah R. Morgan (Author), Jessica Whiteley (Author), Emma Donald (Author), John Smith (Author), Marcia T. Eisenberg (Author), Eddie Kallam (Author), Lauren Kam-Morgan (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples
by: Shethah R. Morgan, et al.
Published: (2012) -
Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy
by: Sissel Gyrid Freim Wahl, et al.
Published: (2021) -
Circulating cell-free DNA biomarkers
by: Jose Rafael Villarreal Escorcia
Published: (2021) -
New methods for analysing circulating cell‐free mitochondrial DNA
by: Nicole Noren Hooten
Published: (2022) -
Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia
by: Mézes Miklós, et al.
Published: (2009)